Evidence map›Paper›PMID 36632306›Full record

ReviewReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2022

Hypofractionation as a solution to radiotherapy access in latin america: expert perspective.

Marcos Santos, Jessica Chavez-Nogueda, Juan Carlos Galvis, Tomas Merino, Luis Oliveira E Silva, Mariana Rico, Gustavo Sarria, Ignacio Sisamon, Onix Garay

Open access · diamondAbstract readReview
In one paragraph

Review in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Moderate hypofractionated radiotherapy to the prostate bed with or without pelvic lymph nodes: a prospective trial.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Marcos SantosALATRO - Latin America Society of Therapeutic Radiation Oncology, Goiânia, Brasil.
Jessica Chavez-NoguedaRadiation Oncology Department, Hospital de Oncología, Centro Médico Nacional Siglo XXI, IMSS, México City, México.
Juan Carlos GalvisDivision of Radiation Oncology, Clinica Los Nogales, Division of Clinical Research Clinica Los Nogales, Bogota, Colombia.
Tomas MerinoHemato-Oncology Department, Pontifícia Universidad Católica de Chile, Santiago, Chile.
Luis Oliveira E SilvaBrasilia University Hospital (Hospital Universitário de Brasília - HUB), Brasília, Brasil.
Mariana RicoAmericas Health Foundation (AHF), Washington, United States.
Gustavo SarriaRadiation Therapy Department, Oncosalud - AUNA, Lima, Peru.
Ignacio SisamonCentro de Oncologia y Radioterapia and Hospital Privado de Comunidad, Mar del Plata, Argentina.
Onix GarayNational Autonomous University of Mexico (UNAM)/Mexican Social Security Institute (IMSS), México City, Mexico.
Centro Medico Nacional Siglo XXI · MXEsSALUD · PEHospital Universitário de Brasília · BRPontificia Universidad Católica de Chile · CLUniversidad Fraternidad de Agrupaciones Santo Tomás de Aquino · ARUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Limited radiation therapy resources have resulted in an interest in developing time and cost-saving innovations to expand access to cancer treatment, in Latin America. Therefore, hypofractionated radiotherapy (HRT) is a possible solution, as this modality delivers radiation over a shorter period of time. Materials and methods: A selected panel of Latin American (LA) experts in fields related to HRT were provided with a series of relevant questions to address, prior to the multi-day conference. Within this meeting, each narrative was discussed and edited, through numerous rounds of discussion, until agreement was achieved. Results: The challenges identified in increasing the adoption of HRT in LA include a lack of national and regional clinical practice guidelines and cancer registries; a lack of qualified human resources and personnel education; high up-front costs of equipment; disparate resource distribution and scarce HRT research. An analysis for these overarching challenges was developed and answered with recommendations. Conclusion: Extending the adoption of HRT in LA can provide a path forward to increase access to radiotherapy and overcome the shortage of equipment. HRT has the potential to improve population health outcomes and patient centered care, while offering comparable local control, toxicity, palliation, and late effects for multiple indications, when compared to conventional RT. Concerted efforts from all involved stakeholders are needed to overcome the barriers in adopting this strategy in LA countries. The recommendations presented in this article can serve as a plan of action for HRT adoption in other countries in a similar situation.

Indexed as

accesscancer carehypofractionated radiotherapyLatin Americaoncology

Identifiers

PMID36632306
PMCPMC9826647
OpenAlexW4310864091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.